mod-GRF (1-29) Information

Mod-GRF (1-29), also known as CJC-1295 without DAC, is a synthetic peptide hormone used in the field of medical research. It is a modified version of Growth Hormone-Releasing Hormone (GHRH), which is naturally produced in the hypothalamus.

Mod-GRF (1-29) works by stimulating the release of growth hormone (GH) from the pituitary gland. It does this by binding to specific receptors in the pituitary, known as GHRH receptors. Once bound, it triggers a signaling cascade that leads to the secretion of GH into the bloodstream.

One of the main advantages of Mod-GRF (1-29) is its longer half-life compared to natural GHRH. This is achieved by modifying the peptide sequence to make it more resistant to enzymatic degradation. As a result, Mod-GRF (1-29) remains active in the body for a longer duration, allowing for sustained stimulation of GH release.

Mod-GRF (1-29) is often used in combination with a growth hormone secretagogue, such as Ipamorelin, to enhance the overall GH-releasing effect. This combination is known as CJC-1295/Ipamorelin and is commonly used in research related to growth hormone deficiency, muscle growth, and anti-aging interventions.

It is important to note that Mod-GRF (1-29) is not approved for human use and is strictly intended for research purposes. Its use in any form should be done under the guidance and supervision of qualified medical professionals.